Health Trials

Lymphomas/Leukemias With Plasmacytic Differentiation

1

Review clinical trials related to Lymphomas/Leukemias With Plasmacytic Differentiation. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

CAR19BCMA CAR-T Cells for the Treatment of R/R Plasma Cell Neoplasms and Lymphomas/Leukemias With Plasmacytic Differentiation

This is a single arm study to evaluate the safety and efficacy of CAR19BCMA CAR-T cells in the treatment of relapsed/refractory CD19/BCMA positive plasma cell neoplasms and lymphomas/leukemias with plasmacytic differentiation.

Participants needed: 20
Trial details
Phase: Early Phase 1Age: 18-75Biological sex: AllType: InterventionalSponsor: Affiliated Hospital to Academy of Military Medical SciencesUpdated: Apr 8, 2026Locations: 1
Eligibility criteria

Confirmation for either BCMA or CD19 positivity using immunohistochemistry or fl... [+10]

Severe heart failure with left ventricular ejection fraction <50% [+9]

Read more